EPO treatment was observed to increase nNOS expression in ventricular myocytes, and EPO was protective in a mouse model of myocardial ischemia-reperfusion injury from CsCl-induced ventricular arrhythmia via nNOS activity (Burger et al., 2009). Here, EPO is linked to Ventricular arrhythmia.